AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
Log in

NASDAQ:HJLIHancock Jaffe Laboratories News Headlines

$0.34
-0.02 (-4.17 %)
(As of 05/27/2020 12:00 PM ET)
Add
Compare
Today's Range
$0.35
Now: $0.35
$0.35
50-Day Range
$0.27
MA: $0.37
$0.47
52-Week Range
$0.21
Now: $0.35
$2.10
Volume370 shs
Average Volume405,809 shs
Market Capitalization$6.60 million
P/E RatioN/A
Dividend YieldN/A
Beta1.87

Headlines

Hancock Jaffe Laboratories (NASDAQ HJLI) News Headlines

Source:
DateHeadline
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Plans for CoreoGraft First-in-Human StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
www.finanznachrichten.de - May 12 at 5:05 PM
Hancock Jaffe Announces Plans for CoreoGraft First-in-Human StudyHancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
finance.yahoo.com - May 12 at 5:05 PM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces One Year Follow-up Data on VenoValve PatientsHancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces One Year Follow-up Data on VenoValve Patients
www.finanznachrichten.de - April 28 at 2:29 PM
Hancock Jaffe Announces One Year Follow-up Data on VenoValve PatientsHancock Jaffe Announces One Year Follow-up Data on VenoValve Patients
finance.yahoo.com - April 28 at 2:29 PM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Registered Direct OfferingHancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Registered Direct Offering
www.finanznachrichten.de - April 27 at 1:22 PM
Hancock Jaffe Announces Registered Direct OfferingHancock Jaffe Announces Registered Direct Offering
finance.yahoo.com - April 27 at 1:22 PM
Principal Investigator Dr. Jorge Hernando Ulloa Presents Updated VenoValve Data at the 32nd Annual Meeting of the American Venous ForumPrincipal Investigator Dr. Jorge Hernando Ulloa Presents Updated VenoValve Data at the 32nd Annual Meeting of the American Venous Forum
finance.yahoo.com - March 5 at 9:27 AM
Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present Updated VenoValve Data Next Week at the 32nd Annual Meeting of the American Venous ForumHancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present Updated VenoValve Data Next Week at the 32nd Annual Meeting of the American Venous Forum
finance.yahoo.com - February 26 at 9:31 AM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility Study
www.finanznachrichten.de - January 8 at 4:36 PM
Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility StudyHancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility Study
finance.yahoo.com - January 8 at 4:36 PM
Hancock Jaffe Laboratories, Inc.: VenoValve Abstract Published in January 2020 Edition of Journal of Vascular SurgeryHancock Jaffe Laboratories, Inc.: VenoValve Abstract Published in January 2020 Edition of Journal of Vascular Surgery
www.finanznachrichten.de - December 20 at 11:58 AM
VenoValve Abstract Published in January 2020 Edition of Journal of Vascular SurgeryVenoValve Abstract Published in January 2020 Edition of Journal of Vascular Surgery
finance.yahoo.com - December 20 at 11:58 AM
Investors Who Bought Hancock Jaffe Laboratories (NASDAQ:HJLI) Shares A Year Ago Are Now Down 74%Investors Who Bought Hancock Jaffe Laboratories (NASDAQ:HJLI) Shares A Year Ago Are Now Down 74%
finance.yahoo.com - December 19 at 12:31 PM
Hancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November 19 to November 23 in New York CityHancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November 19 to November 23 in New York City
finance.yahoo.com - November 19 at 12:28 PM
Hancock Jaffe Enrolls and Successfully Implants Tenth VenoValve PatientHancock Jaffe Enrolls and Successfully Implants Tenth VenoValve Patient
finance.yahoo.com - November 15 at 5:42 PM
Principal Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Six Month Data at the 20th Congress of Asian Society for Vascular Surgery on October 25, 2019Principal Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Six Month Data at the 20th Congress of Asian Society for Vascular Surgery on October 25, 2019
finance.yahoo.com - October 22 at 5:08 PM
Hancock Jaffe to Present at the Inaugural MicroCap Rodeo Investor Conference on October 16, 2019Hancock Jaffe to Present at the Inaugural MicroCap Rodeo Investor Conference on October 16, 2019
finance.yahoo.com - October 14 at 2:12 PM
Hancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern TimeHancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern Time
finance.yahoo.com - September 26 at 3:05 PM
Hancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) Single Biggest Risk For InvestorsHancock Jaffe Laboratories, Inc.'s (NASDAQ:HJLI) Single Biggest Risk For Investors
finance.yahoo.com - September 19 at 4:24 PM
Hancock Jaffe Laboratories (HJLI) Investor Presentation - SlideshowHancock Jaffe Laboratories (HJLI) Investor Presentation - Slideshow
seekingalpha.com - September 19 at 11:23 AM
The MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin TX.The MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin TX.
finance.yahoo.com - September 19 at 11:23 AM
Hancock Jaffe Appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its Board of DirectorsHancock Jaffe Appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its Board of Directors
finance.yahoo.com - September 17 at 3:13 PM
Hancock Jaffe Medical Advisory Board Member Dr. Steven Elias Presents at International Union of Phlebology Conference in Krakow, PolandHancock Jaffe Medical Advisory Board Member Dr. Steven Elias Presents at International Union of Phlebology Conference in Krakow, Poland
finance.yahoo.com - August 29 at 8:38 AM
Hancock Jaffe to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019Hancock Jaffe to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
finance.yahoo.com - August 27 at 12:09 PM
Hancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man StudyHancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man Study
finance.yahoo.com - August 20 at 10:14 AM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Positive 90 Day Results for CoreoGraft Animal Feasibility StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Positive 90 Day Results for CoreoGraft Animal Feasibility Study
www.finanznachrichten.de - August 14 at 4:02 PM
Hancock Jaffe Reports Positive 90 Day Results for CoreoGraft Animal Feasibility StudyHancock Jaffe Reports Positive 90 Day Results for CoreoGraft Animal Feasibility Study
finance.yahoo.com - August 14 at 11:05 AM
Principle Investigator Dr. Jorge Hernando Ulloa Reports New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the CaribbeanPrinciple Investigator Dr. Jorge Hernando Ulloa Reports New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean
finance.yahoo.com - July 26 at 9:07 AM
HANCOCK JAFFE LABORATORIES INCHANCOCK JAFFE LABORATORIES INC
www.finanznachrichten.de - July 19 at 1:23 PM
Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean On July 25, 2019Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean On July 25, 2019
finance.yahoo.com - July 19 at 1:23 PM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility Study
www.finanznachrichten.de - June 27 at 3:51 PM
Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility StudyHancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility Study
www.baystreet.ca - June 27 at 11:24 AM
Hancock Jaffe Laboratories, Inc.: Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global ConferenceHancock Jaffe Laboratories, Inc.: Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference
www.finanznachrichten.de - June 24 at 5:32 PM
Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global ConferencePrimary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference
finance.yahoo.com - June 24 at 5:32 PM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Hires Brian Roselauf as Director of Research and DevelopmentHancock Jaffe Laboratories, Inc.: Hancock Jaffe Hires Brian Roselauf as Director of Research and Development
www.finanznachrichten.de - June 21 at 9:28 AM
Hancock Jaffe Hires Brian Roselauf as Director of Research and DevelopmentHancock Jaffe Hires Brian Roselauf as Director of Research and Development
finance.yahoo.com - June 20 at 11:30 AM
Hancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global ConferenceHancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global Conference
finance.yahoo.com - June 19 at 3:59 PM
What Kind Of Investor Owns Most Of Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)?What Kind Of Investor Owns Most Of Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)?
finance.yahoo.com - June 19 at 9:52 AM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study
www.finanznachrichten.de - June 13 at 3:58 PM
Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human StudyHancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study
finance.yahoo.com - June 13 at 3:58 PM
Hancock Jaffe Laboratories prices equity offeringHancock Jaffe Laboratories prices equity offering
seekingalpha.com - June 13 at 6:23 AM
Hancock Jaffe Announces Pricing of Public Offering of Common StockHancock Jaffe Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - June 13 at 6:23 AM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve StudyHancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study
www.finanznachrichten.de - June 7 at 5:41 PM
Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve StudyHancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study
finance.yahoo.com - June 7 at 5:41 PM
Hancock Jaffe Enrolls Two Additional Patients for First-in-Human VenoValve StudyHancock Jaffe Enrolls Two Additional Patients for First-in-Human VenoValve Study
finance.yahoo.com - June 3 at 11:27 AM
Hancock Jaffe to Present VenoValve Case Management Report at Expert Venous Management Conference on June 7, 2019Hancock Jaffe to Present VenoValve Case Management Report at Expert Venous Management Conference on June 7, 2019
finance.yahoo.com - May 28 at 11:36 AM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Retirement of Board Chairman Yury ZhiviloHancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Retirement of Board Chairman Yury Zhivilo
www.finanznachrichten.de - May 24 at 11:46 AM
Hancock Jaffe Announces Retirement of Board Chairman Yury ZhiviloHancock Jaffe Announces Retirement of Board Chairman Yury Zhivilo
finance.yahoo.com - May 24 at 11:46 AM
Hancock Jaffe Expands CoreoGraft Feasibility StudyHancock Jaffe Expands CoreoGraft Feasibility Study
finance.yahoo.com - May 21 at 12:14 PM
Hancock Jaffe Announces Successful Third Implantation for CoreoGraft Study at Texas Heart InstituteHancock Jaffe Announces Successful Third Implantation for CoreoGraft Study at Texas Heart Institute
finance.yahoo.com - May 1 at 11:32 AM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.